Microbiotica Ltd.

Biotechs developing microbiome modulators are benefitting from improved investor sentiment as strong clinical outcomes de-risk investment and one key player, Microbiotica Ltd. , has just raised an im

Morningside Ventures launched Adiso Therapeutics on 10 March with more than $60m invested to date in the Concord, MA-based start-up focusing on the underlying biology of inflammatory diseases without

Paris-based Seventure Partners established its life sciences team back in 2001 and specializes in the convergence of the health and nutrition sectors. Its focus is on the microbiome, which the company

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Altimmune Targets Upstream A